Witheringia solanacea
Witheringia solanacea · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Witheringia solanacea is a botanical species that has garnered significant attention for its potential therapeutic applications. Research specifically focuses on its antidiabetic activities, highlighting its importance in managing blood glucose levels. The medicinal properties are primarily concentrated within the plant's leaves, which serve as the main source of bioactive compounds. Scientists utilize various preparations to study these effects, including fresh or dried hidroalcoholic extracts and methanolic extracts. Understanding these specific chemical profiles is crucial for advancing the plant's role in modern phytotherapy.
- Synonyms
- Bassovia Macrophylla · Bassovia Solanacea · 25 more
- Common names
- Not available
- Family
- Solanaceae
- Distribution
- Africa
- Plant Parts
- Leaf
Classification
Synonyms
Witheringia solanacea is a plant species that has been identified by several different botanical names throughout its taxonomic history. It is closely associated with various synonyms, including the names Bassovia macrophylla and Bassovia solanacea. The plant's classification also encompasses the specific variety known as Bassovia solanacea var. glabrescens. Furthermore, historical records link this species to the names Brachistus hebephyllus and Brachistus macrophyllus. Understanding these overlapping nomenclature relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Witheringia solanacea is a distinct botanical organism belonging to the vast kingdom Plantae. Within this expansive kingdom, it is specifically classified under the class Equisetopsida. The species is further organized into the order Solanales, reflecting its evolutionary lineage. It belongs to the unique genus Witheringia, which distinguishes it from other similar plants. Finally, its taxonomic placement is completed within the well-known family Solanaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Solanaceae |
| Genus | Witheringia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Witheringia solanacea is a plant species primarily distributed across various regions of North America. Its presence is particularly widespread throughout Mexico, spanning several distinct geographic zones. The plant can be found in the central territories as well as along the Gulf coast. Furthermore, its range extends into the northeast and southeast portions of the country. This diverse distribution also includes the arid landscapes of the Mexican southwest.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Witheringia solanacea is a self-supporting plant that adopts the growth form of a small tree. It reaches a maximum height of approximately 3.5 meters as it matures. This structure allows the species to establish a steady presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Witheringia solanacea is a small shrub from the Solanaceae family that has long been utilized in Costa Rican herbal medicine. Recent scientific studies have focused on evaluating its medicinal potential, specifically regarding its effects on blood glucose regulation. Research involving rodent models demonstrated that aqueous extracts of the plant's leaves possess significant hypoglycemic and antihyperglycemic activity. Specifically, doses of 500 and 1000 mg/kg were found to effectively decrease blood glucose levels in both normal and alloxan-induced diabetic rats. These findings provide strong empirical support for the traditional use of this plant as an antidiabetic treatment.
Compounds
Witheringia solanacea serves as a valuable source of bioactive compounds, specifically within its leaf extracts. Researchers have successfully isolated several key constituents from the plant, including physalin D (3) and physalin F (2). These specific physalins have demonstrated significant potential as modulators of the NF-kappaB cascade. In particular, physalin F (2) showed strong inhibitory activity against PMA-induced activation and helped induce apoptosis in certain leukemia cell lines. While both compounds are present in the plant, the unique structural features of physalin F are believed to be central to its specific anti-inflammatory properties.
Conditions
Witheringia solanacea demonstrates significant medicinal potential through its ability to treat Herpes simplex 1 and Leishmania sp. Research indicates that its extracts effectively inhibit NF-kappaB activation, which is a key component in various inflammatory processes. Specifically, the plant's compounds have been shown to suppress PMA-induced NF-kappaB activation in specialized cell lines. Furthermore, it possesses the capability to treat TNF-alpha-induced NF-kappaB activation through the canonical pathway. These diverse biological activities highlight the plant's multifaceted therapeutic value against viral, parasitic, and inflammatory targets.
Preparations
Witheringia solanacea is prepared as fresh or dried hidroalcoholic extracts to investigate its potential anti-leishmanial activity. These specific extracts were tested against Leishmania sp. strains, showing promising results with IC50 values ranging from 15.9 to 98.1 μg/mL. Additionally, Witheringia solanacea is prepared as methanolic extracts for the screening of medicinal plants from El Salvador. This methanolic preparation demonstrated significant anti-viral activity against Herpes simplex virus 1. Consequently, both preparation methods highlight the plant's medicinal potential against different pathogens.
Parts used
Witheringia solanacea is a small shrub belonging to the Solanaceae family that holds significant medicinal value. Research indicates that the plant's leaves are a primary component used to prepare aqueous extracts for therapeutic purposes. These leaf extracts have demonstrated notable hypoglycemic and antihyperglycemic effects in rodent models, supporting its traditional use in herbal medicine. Furthermore, bioactive compounds known as physalins can be isolated from the leaves to modulate inflammatory pathways. Specifically, these leaf-derived compounds show potential in inhibiting NF-kappaB activation and inducing apoptosis in certain cell lines.